Pharma/Biotech Stocks to Watch This Prostate Cancer Month

Four pharma/biotech companies are set to release earnings .....»»

Progenics Pharmaceuticals' (PGNX) shares down on disappointing results from phase III study evaluating imaging agent, 1404, for prostate cancer detection. .....»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 18.) read more.....»»

The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»

Courtesy Agios Pharma veteran Jackie Fouse.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 30) Acceleron Pharma .....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 22) read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 22) Acer Therapeutics Inc (NASDAQ: ACER) Avanos Medical Inc (NYSE: AVNS) CareDx.....»»

InvestorPlace - Stock.....»»

The development-stage biotechnology company Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) uses protein interaction to treat myelofibrosis, in addition to addressing prostate cancer and other tumors. Latest Ratings for CNST DateF.....»»

With hundreds of biotech stocks all assuring big prospects, building a portfolio of truly transformative medicine makers is a feat. B. Riley FBR said it's found two winners.  Latest .....»»

Let's see how pharma/biotech stocks.....»»

The biotech sector makes a sharp rise in 30 days post the positive data read out from Biogen's mid-stage Alzheimer's trial on BAN2401. We recommend a few industry playe.....»»

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Biotech stocks held their ground in a holiday-shortened week amid a drought of market-moving catalysts. Looking ahead, the following are catalytic events for biotech investors to watch.  read more.....»»

Here's a roundup of top developments in the biotech space since Tuesday morning. Scaling the Peaks (Stocks hitting 52-week highs on July 3) read more.....»»

Your Daily Pharma Scoop: Review Of 3 More Stocks From The Biotech Boom IPO Week (18 - 22 June).....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 2) read more.....»»

Your Daily Pharma Scoop: Review Of 3 Stocks From The Biotech Boom IPO Week (18 - 22 June).....»»

The United States Oil Fund LP (ETF) (NYSE: USO) is down 7.6 percent in the past month as investors anticipate the next major OPEC meeting this week. read more.....»»